公司資料
Cybin 股價、新聞與催化劑
- 股票代碼:
- CYBN
- 交易所:
- AMEX
- 產業:
- Biopharma
- 所在地:
- Canada and listed in the U
股價為何變動
Current closing-price context is not available for CYBN.
公司概覽
業務概覽
Cybin is a biotechnology company focused on psychedelic-inspired mental health therapeutics. Its story is built around developing new treatments for depression and other psychiatric conditions through psychedelic-derived science.
所在地與產業分類
Cybin is headquartered in Canada and listed in the U.S. market. It sits in neuroscience biotechnology with a novel-therapeutics profile.
商業模式特徵
The company depends on clinical validation, regulatory progress, and the ability to translate a new therapeutic paradigm into real-world value. Investors usually watch early data, trial design, and capital runway.
生技產業定位
Cybin occupies a speculative but highly visible neuroscience niche within biotech. The stock is sensitive to whether psychedelic-inspired therapy can turn into a durable clinical category.
未來催化劑
- Cybin’s catalysts are psychedelic-neuroscience programs, especially CYB003 and CYB004, where the next clinical or regulatory update can materially move sentiment. The company is still highly dependent on proof of concept.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。